A long-term analysis of patients with early-stage non-small cell lung cancer showed those who received radiation achieved ...

Lung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. For people battling ...

A new targeted therapy is significantly improving lung cancer patient outcomes. The drug is called Osimertinib, or brand name ...

July 19, 2006 –- Patients with early-stage non–small cell lung cancer who are not candidates for surgery now have other noninvasive and potentially lifesaving options. In a paper published in the July ...

A woman with stage three lung cancer is trying to fund private treatment after being told by the NHS it can only offer ...

ATNM-400 is advancing as a first-in-class, multi-tumor Actinium-225 radiotherapy candidate with activity across prostate and lung cancers, two of the largest cancer indications globally New ...

Postoperative radiotherapy (PORT) has long been considered an adjunct to surgical resection in non-small cell lung cancer (NSCLC), particularly in patients with mediastinal nodal involvement. Recent ...

Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are ...

LOS ANGELES--(BUSINESS WIRE)--City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S.

In a small phase II trial, radiation-free treatment with pembrolizumab (Keytruda) and platinum-based chemotherapy alone ...